Kushim Tablets (Gushim) 45-count packages, Label in foreign language

FDA recall notice · announced February 19, 2020 · B And A Trading

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Kushim Tablets (Gushim) 45-count packages, Label in foreign language

Reason for recall

Marketed Without an Approved NDA/ANDA. FDA analysis found product to contain cinobufagin, bufalin, and bufotenine

Notes

Distribution: NY & NJ only
Lot/code information: Lot #: H003
Quantity: 40 packages
Status: Terminated
Products in this recall event:
- Kushim Tablets (Gushim) 45-count packages, Label in foreign language (D-0840-2020)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.